{"data":{"id":3762,"citation":"Laleu B, Gaggini F, Orchard M, Fioraso-Cartier L, Cagnon L, Houngninou-Molango S, Gradia A, Duboux G, Merlot C, Heitz F, Szyndralewiez C, Page P.: First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis. J Med Chem, Volume 53 (21), 2010","title":"First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis.","doi":"10.1021\/jm100773e","doi_url":"https:\/\/doi.org\/10.1021\/jm100773e","pmid":"20942471","pmid_url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/20942471\/","year":2010,"journal":"J Med Chem","volume":"53","issue":"21","page":"7715-7730","authors":[{"first_name":"Cagnon L","last_name":null,"full_name":null},{"first_name":"Duboux G","last_name":null,"full_name":null},{"first_name":"Fioraso-Cartier L","last_name":null,"full_name":null},{"first_name":"Gaggini F","last_name":null,"full_name":null},{"first_name":"Gradia A","last_name":null,"full_name":null},{"first_name":"Heitz F","last_name":null,"full_name":null},{"first_name":"Houngninou-Molango S","last_name":null,"full_name":null},{"first_name":"Laleu B","last_name":null,"full_name":null},{"first_name":"Merlot C","last_name":null,"full_name":null},{"first_name":"Orchard M","last_name":null,"full_name":null},{"first_name":"Page P.","last_name":null,"full_name":null},{"first_name":"Szyndralewiez C","last_name":null,"full_name":null}],"url":"https:\/\/molmedb.upol.cz\/api\/v1\/publications\/3762","landing_page":"https:\/\/molmedb.upol.cz\/publication\/3762","created_at":"2024-05-21T20:13:16.000000Z","updated_at":null}}